Literature DB >> 24621417

Patterns of intrafractional motion and uncertainties of treatment setup reference systems in accelerated partial breast irradiation for right- and left-sided breast cancer.

Ning J Yue1, Sharad Goyal2, Leonard H Kim2, Atif Khan2, Bruce G Haffty2.   

Abstract

PURPOSE: This study investigated the patterns of intrafractional motion and accuracy of treatment setup strategies in 3-dimensional conformal radiation therapy of accelerated partial breast irradiation (APBI) for right- and left-sided breast cancers. METHODS AND MATERIALS: Sixteen right-sided and 17 left-sided breast cancer patients were enrolled in an institutional APBI trial in which gold fiducial markers were strategically sutured to the surgical cavity walls. Daily pre- and postradiation therapy kV imaging were performed and were matched to digitally reconstructed radiographs based on bony anatomy and fiducial markers, respectively, to determine the intrafractional motion. The positioning differences of the laser-tattoo and the bony anatomy-based setups with respect to the marker-based setup (benchmark) were determined to evaluate their accuracy.
RESULTS: Statistical differences were found between the right- and left-sided APBI treatments in vector directions of intrafractional motion and treatment setup errors in the reference systems, but less in their overall magnitudes. The directional difference was more pronounced in the lateral direction. It was found that the intrafractional motion and setup reference systems tended to deviate in the right direction for the right-sided breast treatments and in the left direction for the left-sided breast treatments.
CONCLUSIONS: It appears that the fiducial markers placed in the seroma cavity exhibit side dependent directional intrafractional motion, although additional data may be needed to further validate the conclusion. The bony anatomy-based treatment setup improves the accuracy over laser-tattoo. But it is inadequate to rely on bony anatomy to assess intrafractional target motion in both magnitude and direction.
Copyright © 2014 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24621417     DOI: 10.1016/j.prro.2012.12.003

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  6 in total

Review 1.  Optical and x-ray technology synergies enabling diagnostic and therapeutic applications in medicine.

Authors:  Brian W Pogue; Brian C Wilson
Journal:  J Biomed Opt       Date:  2018-10       Impact factor: 3.170

2.  X-ray-induced acoustic computed tomography for guiding prone stereotactic partial breast irradiation: a simulation study.

Authors:  Yue Zheng; Pratik Samant; Jack Merill; Yong Chen; Salahuddin Ahmad; Dengwang Li; Liangzhong Xiang
Journal:  Med Phys       Date:  2020-06-15       Impact factor: 4.071

3.  Stereotactic Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer: Rationale, Feasibility, and Early Experience Using the CyberKnife Radiosurgery Delivery Platform.

Authors:  Olusola Obayomi-Davies; Thomas P Kole; Bridget Oppong; Sonali Rudra; Erini V Makariou; Lloyd D Campbell; Hozaifa M Anjum; Sean P Collins; Keith Unger; Shawna Willey; Eleni Tousimis; Brian T Collins
Journal:  Front Oncol       Date:  2016-05-23       Impact factor: 6.244

Review 4.  Target motion management in breast cancer radiation therapy.

Authors:  Elham Piruzan; Naser Vosoughi; Seied Rabi Mahdavi; Leila Khalafi; Hojjat Mahani
Journal:  Radiol Oncol       Date:  2021-10-08       Impact factor: 2.991

5.  Comprehensive target geometric errors and margin assessment in stereotactic partial breast irradiation.

Authors:  Xin Zhen; Bo Zhao; Zhuoyu Wang; Robert Timmerman; Ann Spangler; Nathan Kim; Asal Rahimi; Xuejun Gu
Journal:  Radiat Oncol       Date:  2017-09-11       Impact factor: 3.481

6.  Real-time intra-fraction motion management in breast cancer radiotherapy: analysis of 2028 treatment sessions.

Authors:  D Reitz; G Carl; S Schönecker; M Pazos; P Freislederer; M Niyazi; U Ganswindt; F Alongi; M Reiner; C Belka; S Corradini
Journal:  Radiat Oncol       Date:  2018-07-16       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.